PGC-1alpha and Reelin: new players in HAND progression.
PGC-1alpha 和 Reelin:HAND 进程中的新玩家。
基本信息
- 批准号:9362043
- 负责人:
- 金额:$ 39.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAdvocateAffectAnti-Retroviral AgentsAntibodiesAutopsyBDNF geneBindingBiogenesisBlood - brain barrier anatomyBrain-Derived Neurotrophic FactorCalcineurinCell LineCellsClinicalClinical ManagementCognition DisordersCognitiveCommunitiesCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP-Responsive DNA-Binding ProteinDNADataDevelopmentDiseaseDown-RegulationElementsGenesGenetic TranscriptionHIVHIV-1HIV-associated neurocognitive disorderHippocampus (Brain)HumanImpaired cognitionIn VitroInfectionInflammatoryInjectableInjection of therapeutic agentInterventionLaboratoriesLeadLearningLiteratureMeasurementMediatingMemoryMemory LossMemory impairmentMethylationMitochondriaMovementMusNerve DegenerationNeurocognitive DeficitNeurodegenerative DisordersNeuronsNeuropsychologyPathway interactionsPatientsPersonsPhosphorylationPlasmidsProteinsPublishingPyruvateResearchRoleRolipramTestingTimeTissuesToxic effectTransgenic MiceValidationViral ProteinsVirusVirus ReplicationWorkagedbrain tissueconditioned fearexperimental studyhigh throughput screeningin vivoloss of functionmouse modelneuron lossnovelnovel therapeutic interventionobject recognitionpreventprotein Eprotein expressionprotein functiontat Proteintissue/cell culture
项目摘要
SUMMARY
It has been shown that patients carrying HIV-1 accumulate damage to cells and tissues that are not directly
infected by the virus itself (e.g. neurons). Importantly, these include changes known as HIV- Associated
Neurodegenerative Disorder (HAND) leading to the loss of neuronal functions.
HAND is an outstanding problem in the clinical management of HIV-1 patients, because suppression of
infectious virus by c-ART does not completely block neurodegenerative changes. Neuropsychological studies
disclose cognitive alteration (such as loss of Spatial and Declarative Memory) in a substantial proportion of
HIV-1 infected patients, and analysis of post-mortem brain tissues isolated from HIV-1 patients treated with c-
ART show signs of neurodegeneration.
In the absence of HIV-1 infection of neurons, a number of mechanisms have been proposed for HAND,
including indirect inflammatory effects in the CNS and direct effects of viral proteins (e.g. Tat) shed from
activated HIV-1-infected cells. The fact that these viral proteins enter the neurons through several pathways
suggest the presence of many competing mechanisms that can contribute to HAND, each of which has its
advocates. Their relative contributions to clinical disease in vivo remain to be sorted out, and this is an
outstanding problem in HIV research.
Studies from other neurodegenerative diseases described the cAMP responsive-element binding (CREB)-1
protein as a Key Regulator of the Memory. These studies also showed that loss of CREB protein expression
and phosphorylation contributes to the development of neurocognitive impairments such as Spatial and
Declarative Memory Alteration.
Recently, we have obtained data showing a clear-cut effect of HIV-1 Tat on CREB protein phosphorylation
and function in vitro (primary human and mouse neurons and in the neuronal cell line, SH-SY5Y) and in vivo
(in mice injected with Tat then treated with Rolipram [activator of CREB]) (see BACKGROUND AND
PRELIMINARY RESULTS). This finding is exciting for two reasons:
(1) A correlation between CREB protein and neurodegeneration has been well-established in the literature,
suggesting that this may be a significant contributory mechanism in HAND; and
(2) Agents are available which can specifically restore CREB protein levels and function, offering an
opportunity to test directly the contribution of this mechanism in vivo in mice.
Our hypothesis is that Tat contributes to neurodegeneration via reduction of mitochondrial function,
mediated by a decrease in CREB protein activity.
We propose to test this hypothesis in tissue culture cells and in vivo in mice, and verify the intermediate
role of CREB protein using the specific CREB activator: Rolipram.
Therefore, in this revised application, we asked more specific and focus questions that will allow us to
perform additional in vitro and in vivo studies to determine the exact mechanisms used by Tat leading to the
loss of Memory by focusing mainly on the Tat-CREB function and to restore this lost declarative memory and
learning.
Completion of these studies will determine for the first time involvement of HIV-1 Tat in cognitive disorders
such as, Learning Deficit and Spatial & Declarative Memory Impairment that is commonly observed in HIV-
1 patients as well as in aged persons. Using an Intervention (Rolipram) approach to prevent CREB loss of
functions will help establishing a new therapeutic strategy (high throughput screening) to mitigate cognitive
impairments associated with HIV-1 infection in HIV/AIDS patients.
(Since the relation between Tat and BDNF was amply studied, we will propose BDNF experiments to
validate our hypothesis only).
!
总结
已经表明,携带HIV-1的患者会对细胞和组织造成损害,而这些细胞和组织并不直接
被病毒本身感染(例如神经元)。重要的是,这些变化包括被称为艾滋病毒相关的
神经退行性疾病(HAND)导致神经元功能丧失。
HAND是HIV-1患者临床管理中的一个突出问题,因为抑制
通过c-ART感染病毒不能完全阻断神经退行性变化。神经心理学研究
在相当大的比例中揭示认知改变(如空间和陈述性记忆的丧失)
HIV-1感染患者的脑组织,以及从用c-抗HIV抗体治疗的HIV-1患者分离的死后脑组织的分析。
抗逆转录病毒疗法显示出神经退化的迹象。
在没有HIV-1感染神经元的情况下,已经提出了HAND的许多机制,
包括CNS中的间接炎症作用和从CNS中脱落的病毒蛋白(例如达特)的直接作用。
激活HIV-1感染细胞这些病毒蛋白通过几条途径进入神经元
提出了许多竞争机制的存在,可以有助于手,其中每一个都有其
律师它们在体内对临床疾病的相对贡献仍有待整理,这是一个很好的方法。
艾滋病研究中的一个突出问题。
其他神经退行性疾病的研究描述了cAMP反应元件结合(CREB)-1
蛋白质作为记忆的关键调节器。这些研究还表明,CREB蛋白表达的缺失
和磷酸化有助于神经认知障碍的发展,如空间和
声明性内存变更。
最近,我们获得的数据显示HIV-1达特对CREB蛋白磷酸化的明显影响
体外(原代人和小鼠神经元以及神经元细胞系SH-SY 5 Y)和体内
(in用达特注射小鼠,然后用咯利普兰[CREB的激活剂]处理)(参见背景和
初步结果)。这一发现令人兴奋,原因有二:
(1)CREB蛋白和神经变性之间的相关性已经在文献中得到了很好的建立,
表明这可能是HAND中的一个重要贡献机制;以及
(2)可以获得可以特异性地恢复CREB蛋白水平和功能的试剂,
有机会在小鼠体内直接测试这种机制的贡献。
我们的假设是达特通过减少线粒体功能而导致神经变性,
通过CREB蛋白活性的降低介导。
我们建议在组织培养细胞和小鼠体内测试这一假设,并验证中间体
CREB蛋白的作用,使用特定的CREB激活剂:咯利普兰。
因此,在这份修改后的申请中,我们提出了更具体和更有针对性的问题,使我们能够
进行额外的体外和体内研究,以确定达特导致
通过主要关注Tat-CREB功能来恢复这种丢失的陈述性记忆,
学习
这些研究的完成将首次确定HIV-1达特与认知障碍的关系
例如,学习缺陷和空间和陈述性记忆障碍,这是常见的艾滋病毒-
1患者以及老年人。使用干预(Rolipram)方法防止CREB丢失
功能将有助于建立一种新的治疗策略(高通量筛选),以减轻认知障碍
与HIV-1感染相关的损害在HIV/AIDS患者中。
(由于达特和BDNF之间的关系已被充分研究,我们将提出BDNF实验,
仅验证我们的假设)。
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BASSEL E SAWAYA其他文献
BASSEL E SAWAYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BASSEL E SAWAYA', 18)}}的其他基金
PGC-1alpha and Reelin: new players in HAND progression.
PGC-1alpha 和 Reelin:HAND 进程中的新玩家。
- 批准号:
10172814 - 财政年份:2017
- 资助金额:
$ 39.63万 - 项目类别:
Involvement of HIV-1 Vpr in neuronal degeneration.
HIV-1 Vpr 参与神经元变性。
- 批准号:
8337723 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Involvement of HIV-1 Vpr in neuronal degeneration.
HIV-1 Vpr 参与神经元变性。
- 批准号:
8264046 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Involvement of HIV-1 Vpr in neuronal degeneration.
HIV-1 Vpr 参与神经元变性。
- 批准号:
8512828 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Role of microRNA in HIV associated neurological disorder (HAND).
microRNA 在 HIV 相关神经系统疾病 (HAND) 中的作用。
- 批准号:
8213267 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Role of microRNA in HIV associated neurological disorder (HAND).
microRNA 在 HIV 相关神经系统疾病 (HAND) 中的作用。
- 批准号:
8303230 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Involvement of HIV-1 Vpr in neuronal degeneration.
HIV-1 Vpr 参与神经元变性。
- 批准号:
8695505 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Role of microRNA in HIV associated neurological disorder (HAND).
microRNA 在 HIV 相关神经系统疾病 (HAND) 中的作用。
- 批准号:
8469912 - 财政年份:2011
- 资助金额:
$ 39.63万 - 项目类别:
Role of p53 family in neuropathogenesis in AIDS
p53 家族在 AIDS 神经发病机制中的作用
- 批准号:
7555586 - 财政年份:2008
- 资助金额:
$ 39.63万 - 项目类别:
Role of p53 family in neuropathogenesis in AIDS
p53 家族在 AIDS 神经发病机制中的作用
- 批准号:
7665037 - 财政年份:2008
- 资助金额:
$ 39.63万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 39.63万 - 项目类别: